Your search returned 1978 results.

Results
	681.	PCSK9 is a promising prognostic marker in patients with advanced NSCLC. [electronic resource] by Bonaventura, Aldo Grossi, Francesco Montecucco, Fabrizio Producer: 20200306 In: Cancer immunology, immunotherapy : CII vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	682.	Effect of mutations in the PCSK9 gene on the cell surface LDL receptors. [electronic resource] by Cameron, Jamie Holla, Øystein L Ranheim, Trine Kulseth, Mari Ann Berge, Knut Erik Leren, Trond P Producer: 20060816 In: Human molecular genetics vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	683.	Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. [electronic resource] by Cohen, Jonathan Pertsemlidis, Alexander Kotowski, Ingrid K Graham, Randall Garcia, Christine Kim Hobbs, Helen H Producer: 20050301 In: Nature genetics vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	684.	The unique role of proprotein convertase subtilisin/kexin 9 in cholesterol homeostasis. [electronic resource] by Mousavi, S A Berge, K E Leren, T P Producer: 20100105 In: Journal of internal medicine vol. 266 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	685.	The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion. [electronic resource] by Gustafsen, Camilla Kjolby, Mads Nyegaard, Mette Mattheisen, Manuel Lundhede, Jesper Buttenschøn, Henriette Mors, Ole Bentzon, Jacob F Madsen, Peder Nykjaer, Anders Glerup, Simon Producer: 20141029 In: Cell metabolism vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	686.	Mature proprotein convertase subtilisin/kexin type 9, coronary atheroma burden, and vessel remodeling in heterozygous familial hypercholesterolemia. [electronic resource] by Kataoka, Yu Harada-Shiba, Mariko Nakao, Kazuhiro Nakashima, Takahiro Kawakami, Shoji Fujino, Masashi Kanaya, Tomoaki Nagai, Toshiyuki Tahara, Yoshio Asaumi, Yasuhide Hori, Mika Ogura, Masatsune Goto, Yoichi Noguchi, Teruo Yasuda, Satoshi Producer: 20180101 In: Journal of clinical lipidology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	687.	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE. [electronic resource] by Jellinger, Paul S Handelsman, Yehuda Rosenblit, Paul D Bloomgarden, Zachary T Fonseca, Vivian A Garber, Alan J Grunberger, George Guerin, Chris K Bell, David S H Mechanick, Jeffrey I Pessah-Pollack, Rachel Wyne, Kathleen Smith, Donald Brinton, Eliot A Fazio, Sergio Davidson, Michael Producer: 20190415 In: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	688.	PCSK9 inhibitors: an overview on a new promising lipid-lowering therapy. [electronic resource] by Denegri, Andrea Petrova-Slater, Iveta Pasotti, Elena Rossi, Maria Grazia Pedrazzini, Giovanni Battista Moccetti, Tiziano Moccetti, Marco Producer: 20161114 In: Journal of cardiovascular medicine (Hagerstown, Md.) vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	689.	Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms. [electronic resource] by Sahebkar, Amirhossein Di Giosia, Paolo Stamerra, Cosimo Andrea Grassi, Davide Pedone, Claudio Ferretti, Gianna Bacchetti, Tiziana Ferri, Claudio Giorgini, Paolo Producer: 20171106 In: British journal of clinical pharmacology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	690.	Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor. [electronic resource] by Kasichayanula, Sreeneeranj Grover, Anita Emery, Maurice G Gibbs, Megan A Somaratne, Ransi Wasserman, Scott M Gibbs, John P Producer: 20191004 In: Clinical pharmacokinetics vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	691.	Evolving targets for the treatment of atherosclerosis. [electronic resource] by Solanki, Ankita Bhatt, Lokesh Kumar Johnston, Thomas P Producer: 20190221 In: Pharmacology & therapeutics vol. 187 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	692.	Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy. [electronic resource] by Cao, Ye-Xuan Jin, Jing-Lu Sun, Di Liu, Hui-Hui Guo, Yuan-Lin Wu, Na-Qiong Xu, Rui-Xia Zhu, Cheng-Gang Dong, Qian Sun, Jing Li, Jian-Jun Producer: 20200903 In: Journal of translational medicine vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	693.	Peeking into a cool future: genome editing to delete PCSK9 and control hypercholesterolemia in a single shot. [electronic resource] by Fazio, Sergio Tavori, Hagai Producer: 20150522 In: Circulation research vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	694.	[PERSONALIZED APPROACH TO LIPID-LOWERING THERAPY]. [electronic resource] by Scheen, A J Descamps, O S Producer: 20151014 In: Revue medicale de Liege vol. 70 Availability: No items available. Save to lists Add to cart (remove)
	695.	A randomized study of the relative pharmacokinetics, pharmacodynamics, and safety of alirocumab, a fully human monoclonal antibody to PCSK9, after single subcutaneous administration at three different injection sites in healthy subjects. [electronic resource] by Lunven, Catherine Paehler, Tobias Poitiers, Franck Brunet, Aurélie Rey, Jacques Hanotin, Corinne Sasiela, William J Producer: 20150902 In: Cardiovascular therapeutics vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	696.	β-Estradiol results in a proprotein convertase subtilisin/kexin type 9-dependent increase in low-density lipoprotein receptor levels in human hepatic HuH7 cells. [electronic resource] by Starr, Amanda E Lemieux, Valérie Noad, Jenny Moore, Jasmine I Dewpura, Thilina Raymond, Angela Chrétien, Michel Figeys, Daniel Mayne, Janice Producer: 20151026 In: The FEBS journal vol. 282 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	697.	PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a). [electronic resource] by Ferdinand, Keith C Nasser, Samar A Producer: 20160502 In: Cardiovascular drugs and therapy vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	698.	A novel study to examine the association of [electronic resource] by Reddy, S Kaur, Naindeep Singh, Jagtar Producer: 20190207 In: Journal of genetics vol. 97 Availability: No items available. Save to lists Add to cart (remove)
	699.	PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety. [electronic resource] by Roth, Eli M Davidson, Michael H Producer: 20190716 In: Reviews in cardiovascular medicine vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	700.	Indications of PCSK9 inhibitors in clinical practice. Recommendations of the Spanish Sociey of Arteriosclerosis (SEA), 2019. [electronic resource] by Ascaso, Juan Francisco Civeira, Fernando Guijarro, Carlos López Miranda, José Masana, Luis Mostaza, José María Pedro-Botet, Juan Pintó, Xavier Valdivielso, Pedro Producer: 20200102 In: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1978 results.